For the quarter ended December 31, 2025, revenue before reimbursements dropped 11% to $308.5 million, from $347.3 million a year earlier. Crawford & Company recorded a net loss of $7.2 million, or $0.15 per diluted share for both CRD-A and CRD-B, versus net income of $5.7 million in the prior-year quarter.